The Brown Center for Immunotherapy at Indiana University will host its inaugural annual CME conference entitled Advances in Hematology and Oncology. Cell and gene therapies have the potential to greatly improve the prognosis of patients with life-threatening illnesses. A challenge for clinicians is keeping pace with the rapidly advancing technology and clinical applications. Patients also inquire about options based on reports in the press or on the internet. This CME course will increase participant’s understanding of the biology, expected outcomes, and potential adverse events associated with cell and gene therapy. The goal of this program is to improve the knowledge base of clinicians regarding technologic advances, ongoing clinical trials, and FDA approved therapies. The anticipated outcome is empowerment of participants to provide counseling and appropriate referrals based on an improved understanding of current cell and gene therapy treatment options.